Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial

被引：0
|
作者：
Niels H. Brandt-Jacobsen
Marie Louise Johansen
Jon J. Rasmussen
Morten Dalsgaard
Thomas Kumler
Jens Faber
Patrick Rossignol
Morten Schou
Caroline Kistorp
机构：
[1] Copenhagen University Hospital - Rigshospitalet,Department of Endocrinology
[2] University of Copenhagen,Department of Clinical Medicine, Faculty of Health and Medical Sciences
[3] Copenhagen University Hospital - Herlev and Gentofte Hospital,Department of Endocrinology
[4] Copenhagen University Hospital - Herlev and Gentofte Hospital,Internal Medicine
[5] Université de Lorraine,Department of Cardiology
[6] L’Institut National de la Santé et de la Recherche Médicale (URM-S 116),Department de Défaillance Cardiovasculaire Aiguë et Chronique
[7] Centre Hospitalier Régional Universitaire,Centre d’Investigation Clinique Plurithématique 1433
[8] French Clinical Research Infrastructure Network Investigation Network Initiative - Cardiovascular and Renal Clinical Trialists,undefined
[9] L’Institut National de la Santé et de la Recherche Médicale,undefined
来源：
BMC Cardiovascular Disorders | / 23卷
关键词：
Mineralocorticoid receptor antagonist; High-dose eplerenone; Global longitudinal strain; Systolic and diastolic function;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Does high-dose metformin cause lactic acidosis in type 2 diabetic patients after CABG surgery? A double blind randomized clinical trial
    Baradari, Afshin Gholipour
    Habibi, Mohammad Reza
    Khezri, Hadi Darvishi
    Aarabi, Mohsen
    Khademloo, Mohammad
    Jalali, Zahra
    Ghafari, Rahman
    HEART INTERNATIONAL, 2011, 6 (01): : 26 - 30
  • [22] Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes A Randomized Clinical Trial
    de Boer, Ian H.
    Zelnick, Leila R.
    Ruzinski, John
    Friedenberg, Georgina
    Duszlak, Julie
    Bubes, Vadim Y.
    Hoofnagle, Andrew N.
    Thadhani, Ravi
    Glynn, Robert J.
    Buring, Julie E.
    Sesso, Howard D.
    Manson, JoAnn E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (19): : 1899 - 1909
  • [23] High-Intensity Interval Exercise Effectively Improves Cardiac Function in Patients With Type 2 Diabetes Mellitus and Diastolic Dysfunction A Randomized Controlled Trial
    Hollekim-Strand, Siri M.
    Bjorgaas, Marit R.
    Albrektsen, Grethe
    Tjonna, Arnt E.
    Wisloff, Ulrik
    Ingul, Charlotte B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : 1758 - 1760
  • [24] The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial
    Ghorbani, Ali
    Omidvar, Bita
    Beladi-Mousavi, Seyed S.
    Lak, Elena
    Vaziri, Sima
    NEFROLOGIA, 2012, 32 (06): : 790 - 796
  • [25] Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial (vol 18, pg 55, 2019)
    Bizino, Maurice B.
    Jazet, Ingrid M.
    Westenberg, Jos J. M.
    van Eyk, Huub J.
    Paiman, Elisabeth H. M.
    Smit, Jan W. A.
    Lamb, Hildebrandus J.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (01)
  • [26] EMULATING A RANDOMIZED CLINICAL TRIAL (TECOS) USING REAL-WORLD DATA TO ASSESS THE EFFECT OF SITAGLIPTIN ON CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES
    Velasco, V. Rascon
    Argoubi, R.
    Berliner, E.
    Furegato, M.
    Medina, P.
    VALUE IN HEALTH, 2024, 27 (12)
  • [27] Effect of herbal medicine compound promotes beta cell function among type 2 diabetes (T2D) adults: A randomized controlled clinical trial
    Zhang, Zhenyuan
    Gao, Qin
    Li, Sisi
    Zeng, Ziyu
    Zhang, Yi
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 35
  • [28] Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial
    Wykoff, Charles C.
    Brown, David M.
    Reed, Kimberly
    Berliner, Alyson J.
    Gerstenblith, Adam T.
    Breazna, Aurora
    Abraham, Prema
    Fein, Jordana G.
    Chu, Karen W.
    Clark, W. Lloyd
    Leal, Sergio
    Schmelter, Thomas
    Hirshberg, Boaz
    Yancopoulos, George D.
    Vitti, Robert
    JAMA OPHTHALMOLOGY, 2023, 141 (09) : 834 - 842
  • [29] Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes
    Malgorzata Poreba
    Magdalena Mostowik
    Aleksander Siniarski
    Renata Golebiowska-Wiatrak
    Krzysztof Piotr Malinowski
    Maciej Haberka
    Ewa Konduracka
    Jadwiga Nessler
    Anetta Undas
    Grzegorz Gajos
    Cardiovascular Diabetology, 16
  • [30] Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes
    Poreba, Malgorzata
    Mostowik, Magdalena
    Siniarski, Aleksander
    Golebiowska-Wiatrak, Renata
    Malinowski, Krzysztof Piotr
    Haberka, Maciej
    Konduracka, Ewa
    Nessler, Jadwiga
    Undas, Anetta
    Gajos, Grzegorz
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
12345